# Alex Zhavoronkov
Лучшие выпуски подкастов
Обновлено:
Top podcast episodes featuring alex zhavoronkov.
Inside Insilico Medicine’s AI Strategy and Lilly Breakthrough
“This deal [with Eli Lilly, announced on Sunday 29 March] is a combination of an asset licensing and collaboration. We’ve collaborated with Lilly in the past and they are actually one of the most active and expert users of our software,” says Alex Zhavoronkov, founder and co-CEO of Insilico Medicin…
Alex Zhavoronkov: Beating Aging, Designing Drugs and Betting on China | Frameshifts Episode #12
Plenty of people will tell you AI is about to design our drugs. Alex Zhavoronkov already has. His company’s lead candidate, rentosertib, is the first drug with both its biological target and its molecule discovered by generative AI to post real Phase 2 results in humans. That gap, between the pitch…
RRSP02 The state of Life Sciences, pt 2 - How AI relates to human life and longevity with Dr. Alex Zhavoronkov, Insilico Medicine
Life sciences are at a critical inflection point, where scientific innovation, regulatory demands, and patient expectations converge with advances in data and artificial intelligence, positioning IT as a central driver of faster and more effective drug discovery and clinical development.
This week,…
How to Build a Sustainable Longevity Company | Alex Zhavoronkov
This recording with Alex Zhavoronkov is from our Longevity Biotechnology seminar series, hosted online on June 18th, 2026. View the talk along with the visual presentation on our Youtube channel.
Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a clinical-stage biotech building AI plat…
Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Today, we're diving into a series of compelling stories that underscore the dynamic shifts and groundbreaking progress within the industry.
Recently, Akeso's ivones…
EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine, about what it actually takes to turn AI-generated molecules into approved drugs.
What's Covered:
From Laughed-Out-of-the-Room to 33 Candidates — Alex pitc…
Episode 222 – AI is Moving Drug Discovery From Prediction to Generation
The Big Unlock · Alex Zhavoronkov, Founder, CEO and CBO, Insilico Medicine
In this episode, Alex Zhavoronkov, Founder, CEO and CBO of Insilico Medicine, explores how generative AI is reshaping drug discovery and opening new possibilities in longevity research. He explains how AI can move pharmaceu…
Burn The Map: AI, Brain Science, and the Future of Longevity with Andrea Olsen
In This Episode:
We talk to Andrea Olsen about what happens when neuroscience, machine learning, and longevity research stop being separate lanes and start crashing into each other. Andrea is studying computational neural systems, building Luria Health, and thinking way beyond the usual "AI in hea…
Insilico Medicine's AI-designed drug is showing early signs it can slow aging—a real-world biotech application
Insilico Medicine, a clinical-stage biotechnology company founded by Alex Zhavoronkov, has published two landmark studies on its AI-designed drug candidate rentosertib (also referred to as INS018_055 or ISM001-055), developed to treat idiopathic pulmonary fibrosis (IPF), a progressive and fatal lun…
After a busy time in Boston during the Aging Research and Drug Discovery Meeting, Insilico Medicine CEO Alex Zhavoronkov discusses the latest in longevity therapeutics and Insilico's pipeline progress
He describes the biomarkers that researchers and investigators have been using, and how large pharma companies like Lilly and Novo Nordisk have begun to embrace the field. Plus, the logevity component Insilico has built into its IPF trials, and what other programs and targets he calls out.
ПОИСКОВАЯ СИСТЕМА ПОДКАСТОВ
Вы можете использовать наш веб-сайт для поиска подкастов3,823,950и эпизодов195,684,382по людям, местам или темам.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
ИЗМЕНИТЬ
Спасибо, что помогаете поддерживать базу подкастов актуальной.
